We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




3D-Printable Tissue Adhesive with Blood-Repelling Feature to Revolutionize Surgical Wound Closure

By HospiMedica International staff writers
Posted on 27 Feb 2024
Print article
Image: A close-up of the 3D printable adhesive (Photo courtesy of Hyunwoo Yuk)
Image: A close-up of the 3D printable adhesive (Photo courtesy of Hyunwoo Yuk)

Tissue adhesives offer a modern alternative to traditional wound closure methods such as sutures and staples. They come with benefits including reduced damage to tissues, quicker application, and potentially less scarring. However, the current adhesives have their drawbacks, like being time-consuming to apply, requiring a certain level of skill, and causing discomfort to patients. These adhesives may not be as effective on irregularly shaped or moving tissues, and their application can prolong surgical times. Furthermore, they can damage tissues, and the materials may not always integrate well with the body. Now, the development of 3D printable tissue adhesives has introduced a new dimension to wound closure and tissue repair.

Researchers from MIT (Cambridge, MA, USA) have developed a groundbreaking 3D-printable tissue adhesive that demonstrates superior tissue adhesion, quickly seals wounds in various surgical conditions, and features an innovative blood-repelling feature. The adhesive is made of a special ink that combines poly(acrylic acid) and polyurethane. This composition is key to its strong adhesion, with specific chemical groups forming a tight bond with biological tissues. The researchers enhanced the adhesive by adding a hydrophobic matrix, which repels blood and acts as a barrier against bodily fluids, maintaining the adhesive's effectiveness even in bleeding tissues. Most tissue adhesives struggle in such conditions, making it hard to stop bleeding.

Moreover, the addition of a hydrophobic protective matrix in the adhesive further boosts its functionality, providing a shield against bodily fluids and preserving its integrity in challenging bleeding scenarios. In tests, this 3D printable tissue adhesive outperformed existing commercial adhesives in adhering to tissues. This blood-repellent feature makes the 3D printable tissue adhesive a game-changer in the field of biomedical materials. It overcomes the limitations of existing adhesives in bleeding scenarios and could be used in everything from closing wounds to creating bio-integrated devices. The adhesive's capabilities suggest it could revolutionize not just wound closure but also pave the way for a range of tissue-interacting devices. Going forward, the researchers aim to focus on developing devices that interface with soft tissues, using this adhesive as a key component.

"Leveraging the 3D printability of our material opens up exciting possibilities for designing patches with tissue-specific properties, paving the way for more personalized tissue-repair solutions," said Sarah Wu, a Ph.D. candidate in the Department of Mechanical Engineering at MIT.

Related Links:
MIT

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Vital Signs Monitor
Aurus 10

Print article

Channels

Critical Care

view channel
Image: This study is significant as it addresses a treatment approach that has not been extensively studied before (Photo courtesy of 123RF)

Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease

There has been a lack of extensive research on the use of drug-coated balloon (DCB)-only strategy for the treatment of de novo left main coronary artery disease, especially in high bleeding risk (HBR) patients.... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.